Unified clinical trial software
Unified clinical trial software for nutraceutical studies
oomnia brings together the core elements of nutraceutical research, enabling teams to manage clinical evidence generation, participant data, and real‑world variability within one connected environment
INDUSTRY CONTEXT
Why nutraceutical trials are challenging to execute
Nutraceutical clinical studies operate in a complex space between nutrition and pharmaceuticals, where scientific rigor must align with variable regulatory expectations and real‑world usage patterns. Unlike traditional drug trials, nutraceutical studies often need to demonstrate subtle physiological effects across diverse populations and conditions.
Key execution challenges include:
Difficulty defining clear, measurable endpoints for functional or preventive outcomes
Variability in participant response due to diet, lifestyle, and baseline health differences
Inconsistent regulatory requirements across regions and product classifications
Challenges in maintaining blinding due to sensory characteristics such as taste or smell
Smaller study sizes and shorter durations that may limit statistical power
Fragmentation of clinical, behavioral, and observational data sources
UNIFIED PLATFORM
Why unified clinical trial software matters for nutraceutical studies
Nutraceutical trials frequently rely on disconnected tools to manage clinical data, participant-reported outcomes, laboratory results, and digital health inputs. This separation makes it difficult to maintain consistency and produce reliable, evidence‑grade datasets.
A unified clinical trial platform built as a Clinical Research Information System (CRIS) centralizes study operations and data within a single, structured environment.
This approach supports continuous data capture, consistent study execution, and improved visibility across nutraceutical programs.
| Area | Modular eClinical system | Unified clinical trial software (oomnia) |
|---|---|---|
| Data types | Separate systems for clinical, lifestyle, and supplement data | Integrated data across all study inputs |
| Data consistency | Variability from real‑world usage and reporting | Structured and standardized datasets |
| Reconciliation | Manual alignment of multiple data sources | Reduced reconciliation through shared model |
| Monitoring | Limited real‑time tracking of outcomes | Continuous visibility across participants |
| Execution | Disconnected tools and workflows | Coordinated workflows across stakeholders |
| Data quality | Risk of incomplete or inconsistent inputs | Validated and structured data capture |
| Oversight | Distributed study oversight | Centralized monitoring and reporting |
| Scalability | Difficult to expand across populations and regions | Designed for multi‑study and global scale |
CRIS ARCHITECTURE
One unified clinical trial platform for nutraceutical research
oomnia unifies all study components into a single Clinical Research Information System (CRIS), supporting the unique requirements of nutraceutical trials
Supports integration of clinical, nutritional, and lifestyle data
Aligns diverse data types within a consistent model
Allows protocol flexibility without disrupting ongoing studies
Replaces multiple disconnected systems with one coordinated platform
ECOSYSTEM INTEGRATION
How oomnia fits in the nutraceutical research ecosystem
oomnia acts as a central layer connecting systems and stakeholders involved in nutraceutical development
It integrates:
KEY CAPABILITIES
Key capabilities for nutraceutical studies
Adaptive study design for nutraceutical interventions
- Supports a range of study approaches, including preventive, wellness-focused, and functional outcome studies
- Enables adjustment of endpoints, visit schedules, and intervention parameters
- Maintains control and consistency across evolving study protocols
Data capture and quality
- Captures clinical outcomes, supplement intake, behavioral inputs, and lab results in real time
- Combines EDC, CTMS, RTSM, ePRO/eCOA, eTMF, eSource, and eConsent into a unified environment
- Reduces inconsistencies across fragmented data collection methods
Managing variability in participant response
- Supports distributed and hybrid study designs
- Captures lifestyle, adherence, and patient‑reported outcomes alongside clinical data
- Uses structured workflows to improve data completeness and participant engagement
Real‑time visibility into nutraceutical study performance
- Provides centralized dashboards across participants, cohorts, and endpoints
- Enables ongoing monitoring of adherence, safety signals, and outcome trends
- Supports generation of structured datasets for scientific and regulatory use
Integration of biomarkers and functional outcomes
- Connects laboratory data with real‑world participant inputs
- Links supplement intake to physiological and functional endpoints
- Supports holistic analysis of nutraceutical effects across populations
Designed for evidence generation in dietary supplement and functional health research
Unifies fragmented systems across clinical, behavioral, and observational inputs
Adapts to evolving study requirements and regulatory expectations
Simplifies collaboration across sites, participants, and research partners
VALUE PROPOSITION
Why sponsors choose oomnia for nutraceutical studies
Client Testimonials
Collaboration built on trust and innovation
Wemedoo's technology, expertise, and intimate engagement with our team in the development of the EDC, site/patient interface, and metric capabilities are unique. They provided insight and challenged the underlying assumptions to ensure the study's goals and objectives were clearly defined and the operating structure matched with the study's intent. Their system is not a one-size-fits-all and they adapt to the needs of the sponsor, sites, physicians, and the study requirements into a system that merges health information/data and can then become not only informative but actionable.
James Kuras
Vice President of Clinical Affairs and Operations at Centinel Spine
Wemedoo's cross-functional, integrated teams capture EDC set-up, go-live, data capture, data cleaning, and finally data analysis in a globally compliant fashion supporting trials in different geographies including the US. Their speed of addressing customer needs sets in my personal experience industry benchmark whilst keeping these data solutions lean and affordable. Besides the great proprietary systems they use, their integrated team approach with personal responsibility and honest commitment to targeting outcomes differentiates the Wemedoo team from other providers. Wemedoo only made Oxular's key initial trial, a device-drug trial possible, as based on some pre-work, the Wemedoo team could substantially adapt and update the first EDC ideas for a trial under a US FDA IND. The Wemedoo team worked extremely focused on familiarizing US trial sites and clinical CROs with the use of their system, which turned out to be a key success factor of the respective trial. The highly professional and up-to-date capabilities in data sciences were mirrored by customer-centricity and super fast timelines of integrating mandatory adaptations to the data systems.
Friedrich Asmus
Former Chief Medical Officer at OXULAR
All jobs, both large and small, are performed with the same dedication to quality, detail, innovative thinking, and rigor. It is always a pleasure to work with the Wemedoo team.
Georg Mathis, PhD
CEO at Appletree CI Group AG
Wemedoo embodies all the traits desired in a partner in the clinical trial industry – expertise, innovation, reliability, compliance, and attention to detail.
Martina Diminic Smetisko, DMD
Managing Director at Marti Farm Ltd
Their dedication to, and support of, our projects has resulted in clear quality deliverables. They are always there to answer any questions with expertise in a timely manner. I am looking forward to our next project together.
Volodymyr Stus, MD
Biopharmaceutics and Clinical Research Department Manager at Polpharma SA
Complex adaptive trials demand speed, precision, and system stability. With oomnia, Wemedoo's unified clinical trial software maintained continuous drug supply oversight, real-time data capture above 99%, and zero Randomization and Trial Supply Management (RTSM) dispensing errors throughout the study. The study reached database lock within 3 days after Last Patient Last Visit (LPLV), a direct result of integrated EDC–RTSM execution and proactive technical support. Wemedoo's technology and team responsiveness played a key role in meeting aggressive milestones.
Dhiraj Patel, Dr.
Director at Velocious Clinical Research
REGULATORY READINESS
Compliance and data environment readiness
oomnia provides a controlled and traceable environment aligned with regulatory and scientific expectations in nutraceutical research
21 CFR Part 11–aligned records
21 CFR Part 11–aligned electronic records and audit trails for inspection-ready documentation
Global regulatory frameworks
Support for global regulatory frameworks governing dietary supplements across regions
CDISC-compatible data structures
CDISC‑compatible data structures for standardized and submission-ready outputs
Inspection readiness
Designed to support inspection readiness and evidence transparency throughout the study lifecycle
Get Started
Run nutraceutical studies with greater confidence
Connect diverse data sources and study workflows to strengthen evidence generation and improve study execution
Talk to our team